Clinical studies have proven the efficiency of Cartalax in comprehensive prevention and treatment of patients with spinal osteochondrosis, osteoarthritis, osteoporosis, after injuries and fractures, as well as in the prevention of sclerotic and degenerative processes in the spine and joints in elderly patients.
The supplement can be easily combined with conventional medicine or other groups of supplements used for treatment.
Cartalax is well tolerated, with no identified side effects, complications, contraindications and drug dependence.
Usage:
• Arthrosis and arthritis,
• Osteochondrosis,
• Osteoporosis,
• Degenerative-dystrophic diseases of joints and spine,
• Rheumatism,
• Consequences after trauma,
• Arthropathy,
• Gout,
• Systemic prevention of bone and joint injuries in elite sports,
• Systemic connective tissue disease,
• Preoperative and postoperative periods before/after joints surgeries,
• Prevention of degenerative processes in the spine and joints in elderly people.
Ingredients:
Peptide complex AC-4 (alanine, glutamic acid, aspartic acid). Other ingredients: microcrystalline cellulose (E460), beetroot sugar, lactose, starch, Tween-80.
Dosage:
Adults: 1 to 2 capsules, once or twice a day before meal, for 1 month. It is advisable to repeat after 3-6 months.
After the course of Cartalax it is recommended to take natural joints and spine peptide SIGUMIR® (2 capsules before meal every morning during 1-2 months).
Form release:
60 capsules of 0.2 g
